Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jane Grant-Kels MD, FAAD
Jane M. Grant-Kels MD, FAAD Advisory Board
Christen Mowad MD
Christen Maria Mowad MD Advisory Board
Eliot Mostow MD, MPH
Eliot N. Mostow MD, MPH Associate Editor
See All Experts
featured
Published in Dermatology

Journal Scan / Research · December 18, 2024

Long-Term Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Hidradenitis Suppurativa

The British Journal of Dermatology

 

 Save  Recommend
 Share

Additional Info

The British Journal of Dermatology
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: Week 104 results from the SUNSHINE and SUNRISE extension trial
Br J Dermatol 2024 Nov 29;[EPub Ahead of Print], AB Kimball, FG Bechara, A Badat, EJ Giamarellos-Bourboulis, AB Gottlieb, GBE Jemec, Z Reguiai, AP Villani, I Alarcon, A Bansal, F Gasperoni, R Martin, B Paguet, L Uhlmann, H Zouater, S Ravichandran, A Alavi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated